- Corporate Officers - C
- Cline Darren S
Insider Trading History of Cline Darren S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cline Darren S since 2015.
This trader's CIK number is 1633639.
At the time of last reporting, Cline Darren S was the Director of Pyxis Oncology, Inc.. (stock ticker symbol PYXS).
Also see all insider trading activities at Pyxis Oncology, Inc..
Note that in the past
Cline Darren S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Gw Pharmaceuticals Plc (GWPH) by Cline Darren S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | GWPH | 0 | $0 | 0 | $0 | 7,356 | $7 |
Yearly summary of insider trading at Pyxis Oncology, Inc. (PYXS) by Cline Darren S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | PYXS | 10,000 | $93,890 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seagen Inc. (SGEN) by Cline Darren S
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | SGEN | 0 | $0 | 41,005 | $2,576,291 | 19,086 | $368,685 |
2017 | SGEN | 0 | $0 | 20,381 | $1,039,190 | 18,955 | $324,537 |
2016 | SGEN | 0 | $0 | 22,768 | $1,204,362 | 20,028 | $399,607 |
2015 | SGEN | 0 | $0 | 15,500 | $647,177 | 0 | $0 |
Insider trading activities at 3 companies by Cline Darren S:
1. Gw Pharmaceuticals Plc (GWPH)
2. Pyxis Oncology, Inc. (PYXS)
3. Seagen Inc. (SGEN)
Table 1. Insider trading of Gw Pharmaceuticals Plc (GWPH) by Cline Darren S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-05-28 | GWPH | Option Ex | 7,356 | .00 | 7 |
Table 2. Insider trading of Pyxis Oncology, Inc. (PYXS) by Cline Darren S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-12-08 | PYXS | Buy | 10,000 | 9.39 | 93,890 |
Table 3. Insider trading of Seagen Inc. (SGEN) by Cline Darren S
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-11-29 | SGEN | Sale | 7,000 | 62.88 | 440,160 |
2018-11-21 | SGEN | Sale | 4,167 | 56.69 | 236,206 |
2018-08-27 | SGEN | Sale | 4,784 | 74.23 | 355,125 |
2018-06-12 | SGEN | Sale | 12,054 | 68.99 | 831,581 |
2018-06-12 | SGEN | Option Ex | 10,086 | 22.34 | 225,270 |
2018-05-09 | SGEN | Sale | 9,000 | 55.33 | 497,979 |
2018-05-09 | SGEN | Option Ex | 9,000 | 15.94 | 143,415 |
2018-05-03 | SGEN | Sale | 4,000 | 53.81 | 215,240 |
2017-09-06 | SGEN | Option Ex | 10,048 | 15.94 | 160,114 |
2017-09-06 | SGEN | Sale | 5,024 | 51.94 | 260,966 |
2017-08-31 | SGEN | Option Ex | 2,907 | 18.46 | 53,663 |
2017-08-31 | SGEN | Sale | 7,569 | 52.51 | 397,478 |
2017-08-28 | SGEN | Sale | 1,788 | 47.90 | 85,636 |
2017-08-07 | SGEN | Option Ex | 6,000 | 18.46 | 110,760 |
2017-08-07 | SGEN | Sale | 6,000 | 49.19 | 295,110 |
2016-12-16 | SGEN | Option Ex | 3,100 | 16.41 | 50,871 |
2016-12-13 | SGEN | Sale | 10,000 | 63.80 | 638,010 |
2016-12-13 | SGEN | Option Ex | 12,761 | 22.28 | 284,315 |
2016-09-09 | SGEN | Option Ex | 4,167 | 15.46 | 64,421 |
2016-09-06 | SGEN | Sale | 5,397 | 46.01 | 248,326 |
2016-08-22 | SGEN | Sale | 1,774 | 46.59 | 82,652 |
2015-08-20 | SGEN | Sale | 2,231 | 42.02 | 93,757 |
2016-06-02 | SGEN | Sale | 3,366 | 42.07 | 141,617 |
2015-11-11 | SGEN | Sale | 5,769 | 45.68 | 263,545 |
2015-08-20 | SGEN | Sale | 2,231 | 42.02 | 93,757 |
2015-03-13 | SGEN | Sale | 7,500 | 38.65 | 289,875 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cline Darren S
(Director of Pyxis Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.